ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Singapore-based Biobot Surgical secured $15.5 million in funding led by ClavystBio. The company develops robotic systems for prostate procedures. The investment will support further development and expansion of its technology.
Tracked by ByteBrief